The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to submit comments to the Center for Medicare & Medicaid Services (CMS) on the Advance Notice of Proposed Rule Making (ANPRM) International Pricing Index (IPI) Model for Medicare Part B Drugs published on October 25 in the Federal Register. To read these comments please download the communication below.